Fingerprint
Dive into the research topics of 'Neoadjuvant Chemotherapy Use in Breast Cancer is Greatest in Excellent Responders: Triple-Negative and HER2+ Subtypes'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Neoadjuvant Chemotherapy Use in Breast Cancer is Greatest in Excellent Responders: Triple-Negative and HER2+ Subtypes
Brittany L. Murphy, Courtney N. Day, Tanya L. Hoskin, Elizabeth B. Habermann, Judy C. Boughey
Research output: Contribution to journal › Article › peer-review
42
Scopus
citations